CME: Eosinophilic Esophagitis: Nutritional Considerations in Pediatric Management

Management Essentials for Pediatric Eosinophilic Esophagitis Patients

Management Essentials for Pediatric Eosinophilic Esophagitis Patients
Review what’s involved in the management of pediatric eosinophilic esophagitis, including triggers to look out for and implementing a dietary plan.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Eosinophilic esophagitis is a chronic, immune-mediated or antigen-mediated disease, and since it requires a clinical and histologic diagnosis, a team of healthcare professionals is needed—from a pediatrician or primary care doctor to a pathologist or gastroenterologist. But diagnosis is only the first step.

    Here to recap the essential elements of a pediatric eosinophilic esophagitis management plan is Dr. Vincent Mukkada.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Vincent A. Mukkada, MD
    Associate Professor of Pediatrics
    Cincinnati Children’s Hospital Medical Center
    University of Cincinnati College of Medicine
    Cincinnati, OH

    Dr. Mukkada receives consulting fees from Shire Pharmaceuticals

    Reviewers/Content Planners/Authors:  

    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • Ann Early Wiehn has nothing to disclose.
    • Jessica McGrory has nothing to disclose.
    • Lawrence Sherman, FACEHP, CHCP has nothing to disclose. 
  • Learning Objectives

    The goal of this activity is to enable effective collaboration and communication between the members of the professional teams who care for pediatric patients with eosinophilic esophagitis.  After participating in this educational activity, participants should be better able to:

    • Summarize the epidemiology and pathophysiology of eosinophilic esophagitis in children.
    • Review the clinical presentation and symptoms for eosinophilic esophagitis in pediatric patients.
    • Plan and implement nutrition management of pediatric patients with eosinophilic esophagitis.
  • Target Audience

    This activity is designed to meet the educational needs of pediatricians, pediatric gastroenterologists, allergists/immunologists, dieticians,and other members of the interprofessional team who are involved in the management of pediatric patients with eosinophilic esophagitis.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Prova Education, designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 
    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.  

  • Commercial Support

    This activity is supported by an independent educational grant from Abbott Nutrition.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Sign up for the Medtelligence newsletters.
Comprehensive Cardiology Education.

Better education for a better you.

* Required

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free